# GPT 5.2 Review - Reviewer 1/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T19:25:34.761736
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_0d1a20535265c40300697ba58198a0819cad4d89ff1efd2853
**Tokens:** 22561 in / 5275 out
**Response SHA256:** fc073f0cb1c0a071

---

## 1. FORMAT CHECK

**Length**
- The manuscript appears to be **~27 pages of main text** (ending at “Acknowledgements/References” around p. 27) plus **appendix/figures to ~p. 31**. So it likely **meets the 25-page minimum** (excluding references/appendix), though the exact count depends on what you classify as appendix material.

**References**
- The bibliography is **thin for a top general-interest economics journal**. It includes a few relevant items (Anderson–Hansen–Rees; Keele–Titiunik; Callaway–Sant’Anna; Sun–Abraham; Boeing/OSMnx), but **misses major strands** of (i) cannabis policy and traffic safety, (ii) drug-testing/reporting selection in FARS, (iii) modern DiD diagnostics and estimators, (iv) spatial RDD best practices, and (v) broader traffic-safety policy/time-series context.
- The paper also frequently makes claims that “prior research documents …” (e.g., pp. 11–13, pp. 22–24) but cites only 1–2 papers, which is **not adequate coverage** for AER/QJE/JPE/ReStud/Ecta/AEJ:EP.

**Prose (paragraph form vs bullets)**
- The **Introduction and most narrative sections are in paragraph form** (good).
- There are bullet lists in Data/Appendix (variable definitions, pipeline steps; pp. ~5–9 and Appendix A), which is acceptable.
- However, the “pipeline” sections (pp. ~7–9) read like a technical report and would need stronger narrative framing for a top journal.

**Section depth**
- Some major sections are **not deep enough** for a general-interest journal:
  - Section 4 (“Showcase: Zooming In”) is largely figure walkthrough; it is not clearly **3+ substantive paragraphs of analytical content per subsection**.
  - Sections 6–8 (“Policy border patterns / Research applications”) are **more aspirational than executed**; they outline designs rather than implement them, so they read as **insufficiently developed** for a top outlet.

**Figures**
- Time-series figures (e.g., Fig. 1, Fig. 3 on pp. ~11–13) have axes and visible data.
- Several **map figures lack key publication-quality elements**: clear scale interpretation, consistent legends, and sometimes sufficient geographic context (e.g., border map figures around pp. ~14–17). For an “atlas,” map readability and interpretability must be impeccable (projection notes, scale bar clarity, north arrow, consistent symbology, binning rules, and sample definition *on the figure*).
- For the bar chart of state THC positivity (Fig. 2 on p. ~12), the axis is fine, but interpretation is fragile given differential testing/reporting. The figure should visually encode **denominator variation** (N with drug records by state), not only the positivity rate.

**Tables**
- Tables shown (Table 1, Table 2; pp. ~7–10) contain **real numbers**, not placeholders. Good.
- Table 2 mixes “eventual legal” grouping with pre-legalization years; the note flags this, but it remains confusing for readers and easily misused.

---

## 2. STATISTICAL METHODOLOGY (CRITICAL)

This is where the paper fails top-journal standards **as currently written**.

### (a) Standard Errors
- There are **no regression tables**, hence **no coefficients with SEs** anywhere.
- Even the “RDD-style plot” (Fig. 15, p. ~31) uses LOESS with a shaded band, but does not provide a design-based inferential procedure (bandwidth choice, local polynomial specification, robust bias correction, clustering, etc.).

**Result:** **FAIL**.

### (b) Significance Testing
- No formal hypothesis tests are conducted. No p-values, no randomization inference, no permutation tests for borders, no placebo-border tests with inference.

**Result:** **FAIL**.

### (c) Confidence Intervals
- Some figures display shaded regions labeled as 95% CI (e.g., Fig. 11, p. ~20), but the construction is not explained in a way consistent with modern causal inference standards, and the analysis is not anchored to an identified estimand.
- Main claims in the abstract (e.g., “THC detected is ~19% vs ~10%”) are presented without uncertainty (no CI), despite substantial state-level heterogeneity and selection into drug testing.

**Result:** **FAIL**.

### (d) Sample Sizes
- N is sometimes reported for figures (e.g., border maps show N; good), but **not systematically**:
  - For every main comparison (legal vs comparison; border-pair comparisons), you need Ns for numerator and denominator, by state and year.
  - For Table 2 Panel D, you give rates but not the underlying N with drug records by state group, nor the distribution across states.

**Result:** **Partial fail** (insufficient for publishability).

### (e) DiD with staggered adoption
- The paper repeatedly claims the dataset “enables event studies / DiD” (Sections 1, 3, 8; pp. ~2–4, ~23–25), but **does not implement any DiD**.
- There is no demonstration that the authors can (or did) avoid TWFE pitfalls; no Goodman-Bacon decomposition, no Sun–Abraham style event study, no Callaway–Sant’Anna ATT(g,t) estimates.

**Result:** **FAIL** for the “cannot pass without proper inference” criterion.

### (f) RDD requirements
- The manuscript motivates spatial RDD (Keele–Titiunik) but does not execute it properly:
  - No principled bandwidth selection.
  - No McCrary-style density test (or spatial analog).
  - No covariate continuity/balance checks at the border.
  - No sensitivity to functional form, donut-hole exclusions near the border, or alternative distance metrics (Euclidean vs travel time; road-network distance).
  - No inference with correct clustering/spatial correlation (border-segment clustering, Conley SEs, randomization inference on border segments).

**Result:** **FAIL**.

### Bottom line on methodology
Under the standards you set (“A paper CANNOT pass review without proper statistical inference”), this manuscript is **unpublishable in its current form** for AER/QJE/JPE/ReStud/Ecta/AEJ:EP. As written, it is a **descriptive data-infrastructure report** with suggestive pictures and unquantified comparisons, not a top-journal economics paper.

---

## 3. IDENTIFICATION STRATEGY

**Current status: not identified.** The paper mostly documents patterns and asserts that certain designs are now feasible.

- **Credibility:** The descriptive patterns (e.g., legal vs illegal differences in THC detection among those with drug records, 2018–2019) are **not causal** and are heavily confounded by:
  1. differential drug testing/reporting across states and over time (you acknowledge this; pp. ~22–24),
  2. compositional differences in crash circumstances, enforcement, and coroner/medical examiner systems,
  3. differences in urbanization, miles driven, demographics, and policing,
  4. selection into the “crashes with any drug record” denominator.

- **Key assumptions:** You mention continuity/parallel-trends concepts in passing (Section 8; pp. ~23–25), but you do not articulate them sharply nor evaluate them.

- **Placebos/robustness:** Essentially absent. For a border design, you need placebo borders (borders between two illegal states; or borders where both are legal in 2018–2019), and placebo outcomes (e.g., seatbelt usage, weather, daylight, vehicle age) to demonstrate continuity.

- **Conclusions vs evidence:** The abstract and conclusion language sometimes reads stronger than warranted. Even if you label the paper “data infrastructure,” statements like “sharp policy discontinuities at borders” (pp. ~2–4, ~14–20) are visually suggestive but **not established statistically**, and can be artifacts of reporting practices.

- **Limitations:** The limitations section is directionally correct (Section 7; pp. ~21–24), but it does not go far enough in explaining how selection could mechanically generate the headline 19% vs 10% THC pattern.

---

## 4. LITERATURE (Missing references + BibTeX)

### What’s missing (and why it matters)

#### A. Modern DiD with staggered adoption & diagnostics
You cite Callaway–Sant’Anna (2021) and Sun–Abraham (2021), which is good, but you omit essential papers used by referees to evaluate staggered DiD validity and implementation.

1) **Goodman-Bacon (2021)** — shows TWFE decomposition and why naive TWFE can be biased.
```bibtex
@article{GoodmanBacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  number = {2},
  pages = {254--277}
}
```

2) **Borusyak, Jaravel, Spiess (2021)** — imputation estimator widely used in event studies.
```bibtex
@article{BorusyakJaravelSpiess2021,
  author = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2108.12419},
  year = {2021}
}
```

3) **Roth, Sant’Anna, Bilinski, Poe (2023)** — pretrend testing and “honest DiD” style sensitivity (referees increasingly expect this logic).
```bibtex
@article{RothSantAnnaBilinskiPoe2023,
  author = {Roth, Jonathan and Sant'Anna, Pedro H. C. and Bilinski, Alyssa and Poe, John},
  title = {What's Trending in Difference-in-Differences? A Synthesis of the Recent Econometrics Literature},
  journal = {Journal of Econometrics},
  year = {2023},
  volume = {235},
  number = {2},
  pages = {2218--2244}
}
```

#### B. Regression discontinuity (including spatial RD best practice)
You cite Keele–Titiunik (2015), but omit the canonical RD reviews and modern inference toolkit.

4) **Imbens and Lemieux (2008)** — canonical practical RD guide.
```bibtex
@article{ImbensLemieux2008,
  author = {Imbens, Guido W. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  number = {2},
  pages = {615--635}
}
```

5) **Lee and Lemieux (2010)** — canonical RD review (JEL).
```bibtex
@article{LeeLemieux2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  number = {2},
  pages = {281--355}
}
```

6) **Cattaneo, Idrobo, Titiunik (2020)** — robust RD inference and the modern standard for bandwidth, RBC, sensitivity.
```bibtex
@book{CattaneoIdroboTitiunik2020,
  author = {Cattaneo, Matias D. and Idrobo, Nicolas and Titiunik, Rocio},
  title = {A Practical Introduction to Regression Discontinuity Designs: Foundations},
  publisher = {Cambridge University Press},
  year = {2020}
}
```

#### C. Traffic fatalities, alcohol policy, and cannabis policy literature
The paper cites Anderson et al. (2013) and a couple others, but the cannabis–driving literature is far larger, and you need to position exactly what is new (geocoding + OSM + borders) relative to prior evidence.

Examples you should consider (at minimum a subset; the point is you need to show command of the domain):
- Santaella-Tenorio et al. (systematic review on cannabis laws and outcomes)
- Aydelotte et al. (traffic fatalities post-legalization; though medical/public health outlet, widely cited)
- Sevigny / Pacula / Powell strands on policy detail and heterogeneity
- Papers on **FARS drug testing discretion/selection** beyond Cook et al. (2020), including NHTSA methodological notes and validation studies.

One example entry (illustrative):
```bibtex
@article{SantaellaTenorio2017,
  author = {Santaella-Tenorio, Juliana and Mauro, Christine M. and Wall, Melanie M. and Kim, Jae Won and Cerd{\'a}, Magdalena and Keyes, Katherine M. and Hasin, Deborah S. and Martins, Silvia S.},
  title = {US Traffic Fatalities, 1985--2014, and Their Relationship to Medical Marijuana Laws},
  journal = {American Journal of Public Health},
  year = {2017},
  volume = {107},
  number = {2},
  pages = {336--342}
}
```
(If you dispute this exact title/outlet match, the broader point stands: you need major reviews/flagship empirical studies in this space.)

#### D. Spatial correlation / inference for geospatial designs
If you pursue border designs, referees will demand correct spatial inference (Conley SEs, randomization inference, cluster-by-border-segment, etc.). You should cite Conley (1999) and more recent applied guidance.

```bibtex
@article{Conley1999,
  author = {Conley, Timothy G.},
  title = {GMM Estimation with Cross Sectional Dependence},
  journal = {Journal of Econometrics},
  year = {1999},
  volume = {92},
  number = {1},
  pages = {1--45}
}
```

---

## 5. WRITING QUALITY (CRITICAL)

### (a) Prose vs bullets
- You mostly comply: Intro/Discussion are paragraphs.
- Still, as a top-journal submission, too much of the paper reads like **project documentation** rather than an economics argument. Sections 2.4–2.5 and the figure walk-throughs (roughly pp. ~7–10 and ~14–20) need rewriting into **claims → evidence → interpretation** structure.

### (b) Narrative flow
- The narrative is: “Here is a dataset; here are some maps; therefore you can do RDD/DiD.” That is a **weak arc** for AER/QJE/JPE/ReStud/Ecta/AEJ:EP.
- To work in a top journal, you need either:
  1) a **central causal question answered** using the dataset (dataset as enabling contribution), or
  2) a “data paper” that meets an exceptionally high bar (benchmark validation, measurement-error quantification, reproducibility, comparisons to existing data products, and demonstrated new findings with inference).

### (c) Sentence quality
- Generally clear, but repetitive and cautious in ways that reduce readability (“This enables… motivates… suggests…”). That is acceptable for a data descriptor, but top journals want **sharp, testable claims** and clear delimitations of what is and is not learned.

### (d) Accessibility
- Non-specialists will struggle with:
  - what exactly “THC-positive among crashes with drug records” means substantively (selection problem),
  - why border discontinuities should be interpreted as policy effects rather than reporting artifacts,
  - why OSM “2024 roads” are acceptable proxies for 2001–2010 crashes (temporal mismatch).
- You do mention these issues (Section 2.2 and Section 7), but they need to be brought forward, simplified, and operationalized (e.g., “Here is a validation exercise; here is the bias direction”).

### (e) Figures/tables as stand-alone
- Many figures are close but not yet “journal ready.” At minimum each map should state:
  - sample definition (years, inclusion criteria),
  - what “No THC finding” means (not tested vs tested negative vs missing),
  - denominator N and numerator n,
  - how snapping threshold affects inclusion.
- Fonts/legends need standardization.

---

## 6. CONSTRUCTIVE SUGGESTIONS (to make it publishable/impactful)

### A. Decide what paper you are writing
Right now it is neither:
- a causal AEJ:EP/AER-style policy evaluation, nor
- a pure data descriptor at the level of *Nature Scientific Data* / *JASA Data Science* rigor.

To target **AEJ:EP / top-5 econ**, you likely need **one flagship causal result** (or two) implemented end-to-end with modern inference.

### B. If you pursue DiD/event study (recommended for 2001–2019)
1. Pre-register / clearly define outcomes:
   - crash counts per VMT (or per population), by county/tract/road class,
   - alcohol-involved fatal crashes (more reliable than THC),
   - “any drug record” as an outcome to quantify reporting changes.

2. Implement **Callaway–Sant’Anna ATT(g,t)** or **Sun–Abraham** event studies with:
   - never-treated controls (WY, NE, KS, ID, UT),
   - explicit cohort definitions (2012 pioneers, 2014–15 wave, 2016–17 wave),
   - clustered SEs (state-level clustering is too coarse with ~14 states; consider county-level with appropriate methods, or wild cluster bootstrap at state).

3. Report:
   - coefficient tables with SEs in parentheses,
   - event-study plots with 95% CIs,
   - Ns and weights,
   - sensitivity to alternative control sets (drop AZ/MT/NM if you use them; they later treat).

4. Add pretrend diagnostics (Roth et al.-style “honest DiD” sensitivity is increasingly expected).

### C. If you pursue spatial RDD (recommended only if you can fix drug-testing selection)
To make a spatial border RD credible:
1. Use a **single border pair** as your main design (e.g., CO–WY or WA–ID), justify why (traffic integration, enforcement regimes, sample size).
2. Define the running variable precisely: signed distance to border (you do), but then:
   - choose bandwidth with accepted methods,
   - estimate local linear with robust bias-corrected inference (Cattaneo et al.),
   - cluster by border segment or use spatial HAC (Conley).
3. Show:
   - McCrary density test (and/or spatial analog),
   - covariate continuity (weather, road type, time of day, speed limit tags, etc.),
   - placebo borders and placebo outcomes,
   - donut-hole and donut-by-road (exclude crashes within X meters of major border crossings to rule out mechanical enforcement differences).

### D. Address the core measurement problem head-on (THC)
If THC is central to your story, you must do more than warn that it’s imperfect:
- Decompose “no THC finding” into:
  1) tested negative,
  2) test not given,
  3) missing/unknown coding differences.
- Model selection into testing explicitly (e.g., bounding exercises; inverse probability weighting using observables; or treat testing as an outcome and show whether legalization shifts testing propensity).

### E. Validate geocoding and OSM snapping
Top outlets will ask:
- How often does snapping change the implied road class? How sensitive are results to the 200m threshold?
- Provide histograms of snap distances by state/year; show robustness excluding high snap distances (e.g., >50m, >100m).
- For a sample of crashes, validate location accuracy against narrative location fields (county, route number, mileposts).

### F. Tighten claims and restructure
- If it remains a data paper, reframe as **measurement + validation + new stylized facts** with uncertainty quantification (not just pictures).
- The abstract currently reads like a policy evaluation lead-in; you should either (i) actually evaluate policy causally, or (ii) explicitly brand it as a *data descriptor* and downgrade policy-effect language.

---

## 7. OVERALL ASSESSMENT

### Key strengths
- Valuable integration of **FARS geocodes + OSM road attributes + policy timing**, with replication code promised.
- Clear descriptive documentation of geocoding improvements over time (Fig. 12; pp. ~21–22).
- The border-mapping idea is promising and underused in this domain.

### Critical weaknesses (fatal for top journals as-is)
1. **No statistical inference** (no regression results, SEs, CIs for main comparisons, formal tests).
2. **No implemented identification strategy**: DiD and spatial RDD are proposed, not executed to modern standards.
3. **THC measurement and selection** are too severe to support strong interpretations without additional work.
4. **Literature positioning is incomplete** for both econometric methods and the cannabis/traffic domain.
5. Presentation is closer to a **project report/atlas** than a top-journal economics paper with a sharp estimand and credible design.

### Specific actionable improvements
- Pick one estimand (e.g., effect of recreational possession legalization on alcohol-involved fatal crash rates) and deliver a full modern DiD.
- Or pick one border RD (CO–WY) and deliver a full RD with bandwidth sensitivity, density tests, covariate balance, placebo borders, and correct spatial inference.
- Make THC analysis secondary unless you can convincingly address differential testing/reporting.

DECISION: REJECT AND RESUBMIT